Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases. / Gamborg, Helle; Riis, Jette; Christrup, Lona Louring; Krantz, Torben.

In: Journal of Opioid Management, Vol. 9, No. 4, 2013, p. 269-74.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Gamborg, H, Riis, J, Christrup, LL & Krantz, T 2013, 'Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases', Journal of Opioid Management, vol. 9, no. 4, pp. 269-74. https://doi.org/10.5055/jom.2013.0168

APA

Gamborg, H., Riis, J., Christrup, L. L., & Krantz, T. (2013). Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases. Journal of Opioid Management, 9(4), 269-74. https://doi.org/10.5055/jom.2013.0168

Vancouver

Gamborg H, Riis J, Christrup LL, Krantz T. Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases. Journal of Opioid Management. 2013;9(4):269-74. https://doi.org/10.5055/jom.2013.0168

Author

Gamborg, Helle ; Riis, Jette ; Christrup, Lona Louring ; Krantz, Torben. / Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases. In: Journal of Opioid Management. 2013 ; Vol. 9, No. 4. pp. 269-74.

Bibtex

@article{1068af441a024260bec81f11f32c7be8,
title = "Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases",
abstract = "Dyspnea is considered as one of the most frequent and distressing symptoms in patients with advanced cancer, and systemic administration of morphine has been reported to have beneficial effect on this complaint.",
keywords = "Administration, Oral, Adult, Aged, Aged, 80 and over, Analgesics, Opioid, Chronic Pain, Denmark, Double-Blind Method, Dyspnea, Female, Heart Rate, Humans, Injections, Subcutaneous, Lung Neoplasms, Male, Middle Aged, Morphine, Respiratory Rate, Terminal Care, Time Factors, Treatment Outcome",
author = "Helle Gamborg and Jette Riis and Christrup, {Lona Louring} and Torben Krantz",
year = "2013",
doi = "10.5055/jom.2013.0168",
language = "English",
volume = "9",
pages = "269--74",
journal = "Journal of Opioid Management",
issn = "1551-7489",
publisher = "Weston Medical Publishing, LLC",
number = "4",

}

RIS

TY - JOUR

T1 - Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases

AU - Gamborg, Helle

AU - Riis, Jette

AU - Christrup, Lona Louring

AU - Krantz, Torben

PY - 2013

Y1 - 2013

N2 - Dyspnea is considered as one of the most frequent and distressing symptoms in patients with advanced cancer, and systemic administration of morphine has been reported to have beneficial effect on this complaint.

AB - Dyspnea is considered as one of the most frequent and distressing symptoms in patients with advanced cancer, and systemic administration of morphine has been reported to have beneficial effect on this complaint.

KW - Administration, Oral

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Analgesics, Opioid

KW - Chronic Pain

KW - Denmark

KW - Double-Blind Method

KW - Dyspnea

KW - Female

KW - Heart Rate

KW - Humans

KW - Injections, Subcutaneous

KW - Lung Neoplasms

KW - Male

KW - Middle Aged

KW - Morphine

KW - Respiratory Rate

KW - Terminal Care

KW - Time Factors

KW - Treatment Outcome

U2 - 10.5055/jom.2013.0168

DO - 10.5055/jom.2013.0168

M3 - Journal article

C2 - 24353020

VL - 9

SP - 269

EP - 274

JO - Journal of Opioid Management

JF - Journal of Opioid Management

SN - 1551-7489

IS - 4

ER -

ID: 46132181